文献速递烧伤创面修复

英国成人与儿童烧伤患者静脉血栓预防实践调查

Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom.
PubMed 文献 · Burns · 2019-05-10

该研究通过标准化问卷调查英国所有住院烧伤服务机构的静脉血栓栓塞症(VTE)预防实践,23家机构参与(应答率92%)。84%的烧伤服务提供常规VTE预防,多数采用药物预防联合血栓栓塞 deterrent 弹力袜,所有机构均使用低分子肝素(LMWH)。成人烧伤服务均使用VTE预防方案,但儿童服务中仅56%有方案。

要点

  • 英国84%的烧伤服务提供常规VTE预防,主要使用LMWH联合弹力袜。
  • 所有治疗成人的烧伤服务均有VTE预防方案,但儿童服务仅56%有方案。
  • 多数服务在患者恢复活动后停止预防,缺乏前瞻性数据导致实践差异。

核心结论

  • 烧伤患者是VTE高危人群,尽管真实发病率未知,但预防获益大于风险。
  • 英国烧伤服务VTE预防实践存在差异,尤其儿童患者,需共识和指南标准化实践。

研究设计与样本

  • 横断面调查,联系英国所有住院烧伤服务机构,通过标准化问卷收集VTE实践数据。

主要发现

  • 84%的烧伤服务提供常规VTE预防,多数联合使用化学预防和血栓栓塞 deterrent 弹力袜(TEDS)。
  • 所有机构均选择低分子量肝素(LMWH)作为化学预防药物。
  • 治疗成人的服务全部使用VTE预防方案,但儿童服务中仅56%有方案。
  • 多数服务在患者可活动后停止预防。
  • 既往加拿大和美国调查显示常规VTE预防率分别为50%和76%。

关键数值与推荐

  • 症状性VTE在烧伤人群中的发生率为0.2-7%。
  • 使用LMWH可将肝素相关风险(出血并发症和肝素诱导的血小板减少症)进一步降低至0.1%。
  • 美国调查中71家中心里30%使用间歇充气加压装置(SCD)联合肝素,24%完全不提供VTE预防。

临床怎么用

  • 成人烧伤患者应常规评估VTE风险并实施预防,首选LMWH联合机械预防。
  • 儿童烧伤患者VTE预防方案使用率较低,需加强风险评估和方案制定。
  • 急性烧伤患者可考虑更高剂量LMWH并常规监测抗Xa因子水平。
  • 患者恢复活动后可考虑停止预防,但需个体化评估。

局限性

  • 缺乏烧伤患者VTE的前瞻性数据,实践差异大。
  • 调查基于问卷,可能存在报告偏倚。
  • 未量化VTE真实发病率,预防方案缺乏统一标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with burn injuries are at an increased risk of venous thromboembolism (VTE). This predisposition is secondary to the endothelial injury, hyper-coagulable state and stasis (Virchow's triad) associated with burn injury. Although the true incidence of VTE in burn patients has not been adequately quantified, symptomatic VTE occurs in 0.2-7% of this population. VTE prophylaxis has proven clinical effectiveness and affords a reduction in the morbidity associated with such events, but the benefits and risk of complications need to be balanced in order to provide the best quality of care. Owing to the lack of prospective data on VTE in burns, practice varies greatly, not only internationally, but also between local burns services. Our aim was to better understand current VTE practice within United Kingdom (UK) burn care services by performing a comprehensive survey. METHODS: We contacted all the inpatient burn care services in the UK and collected data on current VTE practice via a standardised questionnaire. Services were given the choice to complete the survey by telephone or email and a follow-up plan was formulated. RESULTS: Twenty-five burn care services were contacted and 23 agreed to participate (92% response rate). Responding services treated adults, children or both and lead burn nurses or senior medical staff familiar with current VTE practice were interviewed. Routine VTE prophylaxis was provided in 84% of burn services and the majority utilised a combination of chemoprophylaxis and thromboembolic deterrent stockings (TEDS). All used low molecular weight heparin (LMWH) as their choice of chemoprophylaxis. Of those treating adults, all used a VTE prophylaxis protocol, but none of these applied to children. Only 56% of services treating children had such a protocol. The majority discontinued prophylaxis once patients were mobile. DISCUSSION AND CONCLUSION: Although the true burden of VTE in burn patients is unknown, we recognise that they are a population at risk. In addition to changes in the inflammatory and clotting pathways associated with thermal injury, prolonged hospital stay, ventilatory support, multiple surgeries, numerous central venous cannulations and reduced mobility all multiply this risk. The risk associated with the administration of heparin (bleeding complications and heparin-induced thrombocytopaenia) is low and can be reduced even further to 0.1% by the use of LMWH. The risk of symptomatic VTE is far greater, therefore the benefits of VTE prophylaxis would seem to outweigh the risks of not undertaking prophylactic measures. A higher LMWH dose and routine monitoring of anti-factor Xa levels are useful for acute burn patients. Two previous surveys, performed in Canada and the United States of America (USA), found routine administration of VTE prophylaxis to be 50% and 76% respectively. Of the 71 centres in the USA participating in the survey, 30% used a combination of sequential compression devices (SCD) and heparin and 24% did not provide VTE prophylaxis at all. A lack of prospective data on VTE in burn patients appears to be associated with diverse practice, and consensus on this topic could ensure that the potential morbidity caused by VTE is reduced. A clinical tool for identifying patients at risk and guidelines for management will standardise practice, which in turn should allow us to improve and maintain high quality care for burn patients.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Vermaak PV, D'Asta F, Provins J, et al. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom. Burns. 2019. PMID: 31079961. doi:10.1016/j.burns.2019.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。